Type 2 Diabetes Linked to Significantly Higher Cancer Risk, Study Finds

Individuals with type 2 diabetes face a heightened risk of developing several aggressive cancers, including breast, bowel, and lung cancer, according to concerning research presented by Danish scientists. The study found that women with the condition are 22% more likely to develop cancer compared to those without, while men face a 12% increased risk.

The elevated risk is particularly pronounced for obesity-related cancers. Men with type 2 diabetes showed a 45% higher likelihood of developing kidney, pancreatic, and liver cancers, and women faced a 30% increased risk. Bowel cancer was found to be approximately 17% more common among people with diabetes, with lung cancer rates up to 25% higher.

Previous data has identified cancer as the leading cause of death for individuals with type 2 diabetes in Britain. The latest findings, presented at the Annual Meeting of the European Association for the Study of Diabetes, reinforce the growing body of evidence connecting obesity, type 2 diabetes, and cancer, as all three conditions become more prevalent.

This trend mirrors an increase in cancer diagnoses among younger adults, with cases rising by a quarter in the 25 to 50 age group over two decades. Experts suggest this rise may be linked to increasing obesity rates, which have doubled in the same period. Concurrently, diagnoses of type 2 diabetes have surged by nearly 70% among young women in England over the past decade.

Dr. Tinne Laurberg, a consultant pathologist at Steno Diabetes Center in Denmark and co-author of the study, emphasized the importance of prioritizing cancer prevention in individuals with type 2 diabetes, especially for common obesity-related cancers like colorectal and post-menopausal breast cancer.

Using nationwide Danish health records from 1996 to 2022, researchers tracked cancer diagnoses in virtually the entire adult population. Over the 27-year period, 75,540 cancer cases were identified among participants with diabetes and 635,323 among those without.

Specific cancer patterns varied by sex. Women with type 2 diabetes had an 8% increased risk of breast cancer. For men, bowel cancer was 17% more likely, though they also showed a 19% lower risk of prostate cancer compared to men without diabetes. Lung cancer rates were approximately 25% higher in women with type 2 diabetes between 2010 and 2022, a notable reversal from an earlier period when they were less likely to develop the disease.

The study's authors are advocating for greater awareness of cancer as a significant long-term risk associated with type 2 diabetes, suggesting it may require increased attention alongside established priorities like cardiovascular and kidney disease prevention.

The researchers cautioned that their findings show an association rather than proving direct causation. The study could not account for factors like body weight, smoking status, alcohol consumption, and physical activity, which may influence the observed differences.

Experts recommend maintaining a healthy weight, regular exercise, and a balanced diet as key strategies to reduce the risk of both type 2 diabetes and cancer. Nine in ten cases of type 2 diabetes are linked to excess weight, and lifestyle changes could prevent around four in ten cases. In the UK, two-thirds of adults are overweight or obese, and nearly a quarter of 10-11 year olds are obese. Obesity is identified as the second-largest preventable cause of cancer after smoking.

Scientists theorize that excess body fat may promote cancer by increasing hormones and growth signals, including insulin, which can stimulate abnormal cell growth. High insulin levels, blood sugar, and chronic inflammation are suspected factors in increasing cancer risk among individuals with diabetes. Hormonal differences may also contribute to the observed sex disparities. The exact reasons for the rising cancer rates in younger populations remain under investigation, with researchers exploring factors such as ultra-processed foods, environmental chemicals, and antibiotic use, alongside obesity trends.